An Exploration of Site Effects in a Multisite Trial of OROS-Methylphenidate for Smokers with Attention Deficit/Hyperactivity Disorder

By Covey Lirio S.   Hu Mei-Chen   Green Carla A.   Brigham Gregory   Hurt Richard D.   Adler Lenard   Winhusen Theresa  

The American Journal of Drug and Alcohol Abuse, Vol. 37, Iss. 5, 2011-09 ,pp. : 392-399

Informa Healthcare

Access to resources Recommend Favorite

An Open-Label Pilot Study of Methylphenidate in the Treatment of Cocaine Dependent Patients with Adult Attention Deficit/ Hyperactivity Disorder

By Somoza Eugene C.   Winhusen Theresa M.   Bridge T. P.   Rotrosen John P.   Vanderburg Douglas G.   Harrer Judy M.   Mezinskis Juris P.   Montgomery Margaret A.   Ciraulo Domenic A.   Wulsin Lawson R.   Barrett Jera A.  

Journal of Addictive Diseases, Vol. 23, Iss. 1, 2004-01 ,pp. : 77-92

Haworth Press

Access to resources Recommend Favorite

Long-Acting Methylphenidate-OROS in Youths with Attention-Deficit Hyperactivity Disorder Suboptimally Controlled with Immediate-Release Methylphenidate: A Study of Cost Effectiveness in The Netherlands

By Faber Adrianne   Michel van Agthoven  

CNS Drugs, Vol. 22, Iss. 2, 2008-01 ,pp. : 157-170

Adis International

Access to resources Recommend Favorite

Present and future pharmacotherapeutic options for adult attention deficit/hyperactivity disorder

By Horrigan J.P.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 573-586

Informa Healthcare

Access to resources Recommend Favorite

Effect of Switching Drug Formulations from Immediate-Release to Extended-Release OROS Methylphenidate: A Chart Review of Spanish Adults with Attention-Deficit Hyperactivity Disorder

By Josep Antoni Ramos-Quiroga   Bosch Rosa   Castells Xavier   Valero Sergi   Nogueira Mariana   Gómez Nuria   Yelmo Silvia   Ferrer Marc   Martínez Yolanda   Casas Miguel  

CNS Drugs, Vol. 22, Iss. 7, 2008-01 ,pp. : 603-611

Adis International

Access to resources Recommend Favorite